PER percheron therapeutics limited

Ann: Change in substantial holding, page-29

  1. 3,170 Posts.
    lightbulb Created with Sketch. 556
    Great analysis, @IronPig. I agree, that the drug has multiple indications, and in this instance, it failed to meet the endpoints of the current trial. Further investigation may reveal some hidden benefits for some individuals in the trial.

    The market appears to have written off the drug completely IMHO. Maybe we are clutching at straws here but the story for Avicursen doesn't end with this one failed trial so I'm still interested to see how things play out in the coming months.

    I guess I'm a glutton for punishment...LOL

    Cheers and good luck
    .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.